Press Releases about Corcept Therapeutics![]() ![]() ![]() ![]() ![]()
Corcept Completes Enrollment in Phase 4 CATALYST Trial
April 29, 2024
Via GlobeNewswire
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]()
Corcept Appoints Roberto Vieira as President, Oncology
January 29, 2024
Via GlobeNewswire
![]() ![]()
Court Finds Corcept Therapeutics’ Patents Not Infringed
January 02, 2024
Via GlobeNewswire
![]() ![]()
Corcept Appoints Monica Tellado as President, Emerging Markets
November 01, 2023
Via GlobeNewswire
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]()
Corcept Therapeutics Initiates CATALYST Clinical Trial
March 28, 2023
Via GlobeNewswire
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions. |
|
Penticton Herald
Phone number: 250-492-4002
E-mail: csr@ok.bc.ca
Address: 186 Nanaimo Ave. W.
Penticton, BC V2A 1N4
© Copyright 2015, Penticton Herald, Penticton, BC. Powered by BLOX Content Management System from TownNews.com.